查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1471238

粒子治疗市场：按治疗类型、成分、成分、癌症类型、最终用户 - 2024-2030 年全球预测

Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年粒子束治疗市场规模为7.7241亿美元，2024年达8.315亿美元，预计2030年将达到13.1887亿美元，复合年增长率为7.94%。

粒子治疗是更广泛的治疗技术中的一个特定部分。它主要关注粒子治疗技术的全球商业化、分销和应用。粒子疗法在受控环境中使用带电和不带电粒子（例如质子和中子）来瞄准并消除患者体内的癌细胞。这种治疗方法在确保精度方面的有效性主要推动了市场需求和成长。癌症治疗中对先进治疗方法的需求不断增长，临床试验中越来越多地采用粒子束疗法，快速、非侵入性且痛苦较小的手术是推动该市场成长的主要因素。另一方面，粒子束治疗的保险范围有限，并且存在与粒子束治疗的辐射暴露相关的风险，这限制了其使用并阻碍了市场成长。然而，多家供应商正在开发更先进、更紧凑的粒子治疗系统，专注于提高准确性并最大限度地减少潜在的副作用。此外，正在进行的质子治疗研究计划和带电粒子治疗的技术进步正在为粒子治疗的扩展创造无数的机会。

主要市场统计
基准年[2023] 77241万美元
预测年份 [2024] 8.315 亿美元
预测年份 [2030] 1,318.87 百万美元
复合年增长率（%） 7.94%

治疗类型：质子疗法受到消费者的青睐，因为它对周围组织损伤的风险较低。

重粒子放射治疗使用碳等高度电离的原子来精确伤害癌细胞。该技术对周围健康组织造成的损害最小。这种治疗方法对放射抗性肿瘤有效，优于传统放射治疗。质子束疗法正变得越来越受欢迎，特别是在小儿科，因为它具有限制对周围组织和器官的损害的特性，这对于肿瘤靠近重要器官的患者来说有很大的不同。重离子疗法为抗辐射肿瘤提供了一种有前景的解决方案，而质子疗法通常是儿童癌症患者的首选，因为它对周围组织损伤的风险较小。

组件：组件产品的使用正在增加，因为它们在治疗重要器官附近的固态肿瘤方面具有高精度。

粒子治疗产品主要由以粒子束照射目标的设备组成。这包括迴旋加速器、同步迴旋加速器和同步加速器等设备。迴旋加速器用于将带电粒子加速到高能量。同步迴旋加速器旨在透过改变加速电场的频率来克服迴旋加速器的频率限制。因此，它可以有效、准确地发射高能量束，使其成为粒子束治疗的理想选择。同步加速器是粒子加速器，是粒子束治疗的理想选择，因为它们可以更好地控制被加速粒子的能量。常用于治疗深部肿瘤和形态复杂的肿瘤。粒子治疗精确地向癌细胞提供高剂量的辐射，并且有多种系统，每种系统都提供独特的好处，具体取决于医疗机构的特定需求和情况。服务部门包括与粒子治疗系统相关的安装、维护、培训和咨询服务。另一方面，癌症患者大量涌入以及支持粒子治疗装置的基础设施的医疗机构对产品组件的需求更为迫切。在医疗机构处于开发或计划开发粒子治疗装置早期阶段的国家，对服务组件的需求较高。

配置：多房间系统可以同时治疗更多患者

多室粒子束治疗系统包含多个治疗室，让更多患者同时接受治疗。此类系统对大型医疗设施非常有利，因为它们允许快速的患者流动、处理复杂病例的能力，并最大限度地提高粒子加速器设施的利用效率。单室系统是希望进入粒子治疗领域的小型医疗机构的理想选择。由于其紧凑的设计和相对简单的物流，它们通常易于部署和管理。相较之下，多房间系统有利于同时治疗更多患者和处理更复杂的病例，但其实施需要更高的初始投资和操作复杂性。另一方面，单室系统由于其紧凑的设计和可管理的物流而更容易安装和操作，使其适合刚开始处理粒子治疗的小型医疗机构。

癌症类型：由于降低了健康组织的风险，粒子疗法在头颈癌的应用正在扩大

粒子束疗法提供高度聚焦的辐射，对于復发性和进行性乳癌患者特别有效。由于头颈癌的解剖结构复杂，粒子治疗已显示出有希望的结果。粒子治疗的精确、高剂量辐射可最大限度地降低肿瘤周围健康组织受到过度辐射的风险。众所周知，肺癌对传统放射疗法具有抵抗力，但粒子束疗法已显示出有希望的治疗效果。粒子疗法在治疗儿童癌症方面也非常有效，可以减少通常与传统放射疗法相关的长期副作用。在前列腺癌的治疗中，粒子束治疗有效、精准的放射技术大大提高了治疗效果。相较之下，粒子束疗法已成为头颈癌治疗领域的新曙光，为与各种疾病作斗争的患者带来了希望。

最终使用者：粒子束治疗在医院和临床环境中发挥重要作用，以提供高品质的医疗照护。

门诊手术中心 (ASC) 使外科医生能够以较低的成本提供高效、高品质的护理。透过粒子束疗法，这些中心可以治疗癌症明确且仅需要少量治疗的病例。医院和诊所提供更全面的治疗并治疗各种癌症病例。我们提供质子和重离子疗法来治疗各种癌症，包括更复杂的问题。这些设施拥有大型治疗设施和先进的粒子治疗设备。由于其业务的性质，日间手术中心力求在有限的空间内提高效率，采用紧凑、流线型的设计，非常适合不太复杂的病例。医院和诊所提供更强大的治疗能力来处理从简单到复杂的各种病例。

区域洞察

在美国，对粒子束治疗的需求不断增长。技术创新频繁发生，并得到私人和公共机构的大力支持。由于广泛的研究活动和众多投资者资助的针对治疗创新的新兴企业的崛起，该地区拥有最大的市场占有率。在欧洲、中东和非洲地区，欧洲的粒子治疗呈现出惊人的成长，这主要是由于各种类型癌症的发生率不断上升以及人口老化的风险不断增加。此外，各国政府和组织增加的医疗资金，加上医疗设施的建立，导致了这项技术的广泛采用。中东和非洲国家也显示出可观的成长，这主要是由于医疗成本不断上升以及加强医疗基础设施的力度加大。在亚太地区，一些国家已采用粒子疗法来治疗癌症。促成这一进步的因素包括癌症盛行率上升、快速都市化以及经济状况的持续改善。亚太地区庞大的人口基数，加上医疗基础设施的改善以及政府对癌症研究和治疗的资助增加，使亚太地区成为快速成长的粒子治疗市场。

FPNV定位矩阵

FPNV定位矩阵对于评估粒子治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对粒子治疗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该细分市场竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的智力见解。

本报告解决了以下关键问题：

1.粒子束治疗市场的市场规模与预测是多少？

2.在粒子束治疗市场的预测期内，我们应该考虑投资哪些产品和应用？

3.粒子束治疗市场的技术趋势和法规结构是什么？

4.粒子束治疗市场主要厂商的市场占有率为何？

5.进入粒子束治疗市场的合适形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症治疗需要先进的治疗方法方法
      • 在临床试验中更多地采用粒子疗法
      • 世界各地的粒子治疗中心不断增加
    • 抑制因素
      • 粒子治疗设备和程序的成本很高，而且粒子治疗的保险范围有限。
    • 机会
      • 正在进行的质子治疗调查计画
      • 带电粒子束治疗的技术进步和个人化癌症治疗策略的实现
    • 任务
      • 与粒子束治疗辐射暴露相关的风险
  • 市场区隔分析
    • 治疗类型：消费者更喜欢质子治疗，因为对周围组织损伤的风险较低
    • 组件：高精度增加了产品组件的使用，以治疗重要器官附近的固态肿瘤
    • 配置：可以同时治疗多个患者的多房间系统的可能性
    • 癌症类型：由于降低了健康组织的风险，粒子疗法在头颈癌的应用不断扩大
    • 最终使用者：粒子治疗在努力提供优质护理的医院和医疗机构中发挥重要作用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章粒子治疗市场：依治疗类型

  • 介绍
  • 重粒子线治疗
  • 质子治疗

第七章粒子治疗市场：依组成部分

  • 介绍
  • 产品
  • 服务

第八章粒子治疗市场：依成分分类

  • 介绍
  • 多房间系统
  • 单间系统

第九章粒子束治疗市场：依癌症类型

  • 介绍
  • 乳癌
  • 头颈癌
  • 肺癌
  • 儿童癌症
  • 摄护腺癌

第 10 章 粒子治疗市场：依最终使用者分类

  • 介绍
  • 门诊手术中心
  • 医院/诊所

第十一章 美洲粒子治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太粒子治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的粒子治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-335201F2E2B6

[193 Pages Report] The Particle Therapy Market size was estimated at USD 772.41 million in 2023 and expected to reach USD 831.50 million in 2024, at a CAGR 7.94% to reach USD 1,318.87 million by 2030.

The particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth. In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 772.41 million
Estimated Year [2024] USD 831.50 million
Forecast Year [2030] USD 1,318.87 million
CAGR (%) 7.94%

Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues

Heavy ion therapy employs densely ionized atoms such as carbon to initiate precise damage to cancer cells. The technique results in minimal damage to surrounding healthy tissue. This therapy is effective on radio-resistant tumors, providing an edge over traditional forms of radiotherapy. Proton therapy is increasingly preferred, especially in pediatrics, due to its damage-limiting property for surrounding tissues and organs, making a significant difference to patients with tumors near critical organs. Heavy ion therapy provides a promising solution for radio-resistant tumors, and proton therapy is often preferred for pediatric cancer patients because of its reduced risk of damage to surrounding tissues.

Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy

Particle therapy products primarily constitute equipment that delivers the target's particle beams. This includes machines such as cyclotrons, synchrocyclotrons, and synchrotrons. Cyclotrons are utilized to accelerate charged particles to high energies. Synchrocyclotrons are designed to overcome the frequency limitation of cyclotrons by altering the frequency of the accelerating electric field. This makes them ideal for particle therapy due to their ability to deliver high-energy beams effectively and accurately. Synchrotrons are particle accelerators but demonstrate more control over the energy of the accelerated particles, making them an excellent choice for particle therapy. They are often utilized in treating deep-seated and complex-shaped tumors. Particle therapy delivers high doses of radiation precisely to tumor cells and comes in different systems where each offers unique benefits depending upon the specific needs and situations of the healthcare establishment. The services segment includes installation, maintenance, training, and consulting services related to particle therapy systems. In comparison, the requirement for a product component is more imminent in countries with health institutes experiencing an influx of cancer patients and having the infrastructure to support a particle therapy unit. The service component's demand is more in countries where healthcare organizations are in the early stages of developing or planning to develop a particle therapy unit.

Configuration: Potential of a multi-room system for treating a larger number of patients concurrently

A multi-room system in particle therapy incorporates multiple treatment rooms, thus allowing more patients to receive treatment concurrently. These systems are immensely beneficial for large healthcare establishments, owing to the faster patient flow, the ability to treat complex cases, and the efficiency in maximizing the usage of particle accelerator facilities. Single-room systems are the ideal choice for smaller healthcare facilities that are starting to venture into the realm of particle therapy. They are generally easier to implement and manage due to the compact design and relatively simpler logistics. In comparison, multi-room systems are beneficial in treating a larger number of patients concurrently and cater to complex cases, and their implementation demands higher initial investment and operational complexity. On the contrary, single-room systems, with their compact design and manageable logistics, are easier to implement and operate, thus being a better fit for smaller healthcare facilities initiating their journey into particle therapy.

Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue

Particle therapy, offering highly focused radiation, has brought about remarkable results in breast cancer management, especially for patients with recurring or aggressive forms of the disease. Particle therapy for head & neck cancer shows promising results due to the anatomical complexity of this region. The precise and high-dosage radiation from particle therapy minimizes the risk of excess radiation in healthy tissues around the tumor. Lung cancer, notorious for its resistance to traditional radiation therapy, has seen promising treatment outcomes through particle therapy. Particle therapy is considerably beneficial in treating pediatric cancers, reducing the long-term side effects usually associated with traditional radiation treatments. Prostate cancer treatment has been dramatically enhanced by particle therapy, given the highly effective and precise radiation techniques. In comparison, particle therapy has emerged as a new dawn in the field of head & neck cancer treatment, offering hope to patients battling various forms of the disease.

End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care

Ambulatory surgery centers (ASCs) allow surgeons to deliver efficient, high-quality care at a lower cost. In particle therapy, these centers cater to instances where the cancer is well-defined and is treated in a few sessions. Hospitals and clinics offer more comprehensive care and cater to various cancer cases. They provide both proton and heavy ion therapies to treat a variety of cancers, including more complex issues. These institutions have large treatment facilities equipped with advanced particle therapy machines. Due to their nature of operation, ambulatory surgery centers embrace compact, streamlined designs best suited for less complex cases, striving for efficiency with limited space. Hospitals & clinics offer more robust treatment capabilities to manage various cases, from the simple to the complex.

Regional Insights

In America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique. Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Particle Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Particle Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy Type
    • Heavy Ion Therapy
    • Proton Therapy
  • Component
    • Product
      • Cyclotrons
      • Synchrocyclotrons
      • Synchrotrons
    • Service
  • Configuration
    • Multi-room System
    • Single-room System
  • Cancer Type
    • Breast Cancer
    • Head & Neck Cancer
    • Lung Cancer
    • Pediatric Cancer
    • Prostate Cancer
  • End-User
    • Ambulatory Surgery Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Particle Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Particle Therapy Market?

3. What are the technology trends and regulatory frameworks in the Particle Therapy Market?

4. What is the market share of the leading vendors in the Particle Therapy Market?

5. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advanced therapies in cancer treatment
      • 5.1.1.2. Rise in adoption of particle therapy in clinical trials
      • 5.1.1.3. Growing number of particle therapy centers worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing proton therapy research programs
      • 5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with the particle therapy radiation exposure
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
    • 5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
    • 5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
    • 5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
    • 5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Particle Therapy Market, by Therapy Type

  • 6.1. Introduction
  • 6.2. Heavy Ion Therapy
  • 6.3. Proton Therapy

7. Particle Therapy Market, by Component

  • 7.1. Introduction
  • 7.2. Product
  • 7.3. Service

8. Particle Therapy Market, by Configuration

  • 8.1. Introduction
  • 8.2. Multi-room System
  • 8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

  • 9.1. Introduction
  • 9.2. Breast Cancer
  • 9.3. Head & Neck Cancer
  • 9.4. Lung Cancer
  • 9.5. Pediatric Cancer
  • 9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Particle Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
    • 14.3.2. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
    • 14.3.3. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 347. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 362. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 363. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLIO